Literature DB >> 30072853

Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.

Alireza Nazeri.   

Abstract

Entities:  

Keywords:  Anti-arrhythmia agents/therapeutic use; anticoagulants/administration & dosage/therapeutic use; atrial fibrillation/drug therapy; risk factors; stroke/prevention & control

Mesh：

Substances：

Year:  2018        PMID： 30072853      PMCID： PMC6059508          DOI： 10.14503/THIJ-18-6678

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  5 in total

1.  2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.

Authors:  John U Doherty; Ty J Gluckman; William J Hucker; James L Januzzi; Thomas L Ortel; Sherry J Saxonhouse; Sarah A Spinler
Journal:  J Am Coll Cardiol       Date:  2017-01-09       Impact factor: 24.094

Review 2.  Old and new oral anticoagulants: Food, herbal medicines and drug interactions.

Authors:  Alessandro Di Minno; Beatrice Frigerio; Gaia Spadarella; Alessio Ravani; Daniela Sansaro; Mauro Amato; Joseph P Kitzmiller; Mauro Pepi; Elena Tremoli; Damiano Baldassarre
Journal:  Blood Rev       Date:  2017-02-05       Impact factor: 8.250

3.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).

Authors:  Gregory Y H Lip; Stephan Windecker; Kurt Huber; Paulus Kirchhof; Francisco Marin; Jurriën M Ten Berg; Karl Georg Haeusler; Giuseppe Boriani; Davide Capodanno; Martine Gilard; Uwe Zeymer; Deirdre Lane; Robert F Storey; Hector Bueno; Jean-Philippe Collet; Laurent Fauchier; Sigrun Halvorsen; Maddalena Lettino; Joao Morais; Christian Mueller; Tatjana S Potpara; Lars Hvilsted Rasmussen; Andrea Rubboli; Juan Tamargo; Marco Valgimigli; Jose L Zamorano
Journal:  Eur Heart J       Date:  2014-08-25       Impact factor: 29.983

Review 4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

5.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Marco Valgimigli; Héctor Bueno; Robert A Byrne; Jean-Philippe Collet; Francesco Costa; Anders Jeppsson; Peter Jüni; Adnan Kastrati; Philippe Kolh; Laura Mauri; Gilles Montalescot; Franz-Josef Neumann; Mate Petricevic; Marco Roffi; Philippe Gabriel Steg; Stephan Windecker; Jose Luis Zamorano; Glenn N Levine
Journal:  Eur Heart J       Date:  2018-01-14       Impact factor: 29.983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.